1. Epigenetics Metabolic Enzyme/Protease Anti-infection
  2. Histone Methyltransferase Phosphodiesterase (PDE) Parasite
  3. Furamidine

Furamidine  (Synonyms: DB75; NSC 305831)

目录号: HY-110137A
产品使用指南 技术支持

Furamidine (DB75) 是一种选择性的且细胞可渗透的蛋白精氨酸甲基转移酶 1 (PRMT1) 抑制剂,IC50 为 9.4 μM。Furamidine 对 PRMT1 的选择性高于 PRMT5,PRMT6PRMT4 (CARM1) (IC50 分别为 166 µM,283 µM 和 >400 µM)。Furamidine 是一种有效的,可逆的和竞争性的酪氨酰 DNA 磷酸二酯酶 1 (TDP-1) 抑制剂。Furamidine 对 TDP-1 的抑制作用对单链和双链 DNA 底物均有效,对双链 DNA 的作用更强。Furamidine 也是一种抗寄生虫剂。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Furamidine

Furamidine Chemical Structure

CAS No. : 73819-26-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Furamidine 的其他形式现货产品:

Customer Review

Other Forms of Furamidine:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Furamidine (DB75) is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 of 9.4 μM. Furamidine is selective for PRMT1 over PRMT5, PRMT6, and PRMT4 (CARM1) (IC50s of 166 µM, 283 µM, and >400 µM, respectively). Furamidine is a potent, reversible and competitive tyrosyl-DNA phosphodiesterase 1 (TDP-1) inhibitor. Inhibition of TDP-1 by Furamidine is effective both with single- and double-stranded DNA substrates but is slightly stronger with the duplex DNA. Furamidine is also an antiparasite agent[1][2][3].

IC50 & Target

IC50: 9.4 μM (Protein arginine methyltransferase 1 (PRMT1)); 166 µM (PRMT5), 283 µM (PRMT6) and >400 µM (PRMT4)[1]
Parasite[1]
Tyrosyl-DNA phosphodiesterase 1 (TDP-1)[2]

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A2780 IC50
15.5 μM
Compound: 2
The compound was tested for cytotoxic potency against A2780R human tumor cell lines.
The compound was tested for cytotoxic potency against A2780R human tumor cell lines.
10.1016/S0960-894X(97)00229-1
A2780 IC50
46 μM
Compound: 2
The compound was tested for cytotoxic potency against A2780 human tumor cell lines
The compound was tested for cytotoxic potency against A2780 human tumor cell lines
10.1016/S0960-894X(97)00229-1
B16 IC50
9.2 μM
Compound: DB75
Drug concentration required to inhibit B16 cell growth by 50% after 72 hours of incubation
Drug concentration required to inhibit B16 cell growth by 50% after 72 hours of incubation
[PMID: 11985467]
CH1 IC50
46.5 μM
Compound: 2
The compound was tested for cytotoxic potency against CH1 human tumor cell lines.
The compound was tested for cytotoxic potency against CH1 human tumor cell lines.
10.1016/S0960-894X(97)00229-1
HEK-293T IC50
166 μM
Compound: 1, DB75, furamidine
Inhibition of HA-tagged recombinant PRMT5 (unknown origin) expressed in HEK293T cells using [3H]SAM and histone H4 (1 to 20) as substrate after 8 mins by P81 filter binding assay
Inhibition of HA-tagged recombinant PRMT5 (unknown origin) expressed in HEK293T cells using [3H]SAM and histone H4 (1 to 20) as substrate after 8 mins by P81 filter binding assay
[PMID: 24564570]
HEK293 IC50
178.04 μM
Compound: 7e; DB75
Cytotoxicity against HEK293 cells assessed as decrease in cell viability after 24 hrs by Alamar blue assay
Cytotoxicity against HEK293 cells assessed as decrease in cell viability after 24 hrs by Alamar blue assay
[PMID: 28038325]
L6 IC50
16.4 μM
Compound: furamidine
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
[PMID: 17439202]
L6 IC50
23.3 μM
Compound: FMD, DB75, Furamidine
Antiprotozoal activity against intracellular amastigote form of Trypanosoma cruzi Tulahuen C2C4 expressing LacZ infected in rat L6 cells after 48 hrs
Antiprotozoal activity against intracellular amastigote form of Trypanosoma cruzi Tulahuen C2C4 expressing LacZ infected in rat L6 cells after 48 hrs
[PMID: 23795673]
L6 IC50
6.4 mM
Compound: FMD
Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay
Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay
[PMID: 23871911]
L6 IC50
6.4 nM
Compound: Furamidine
Cytotoxicity against rat L6 cells by alamar blue assay
Cytotoxicity against rat L6 cells by alamar blue assay
[PMID: 17178177]
L6 IC50
6.4 μM
Compound: 2
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
[PMID: 16913722]
L6 IC50
6.4 μM
Compound: FMD
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
[PMID: 19409677]
L6 IC50
6.4 μM
Compound: FMD
Cytotoxicity against rat L6 cells by Alamar blue assay
Cytotoxicity against rat L6 cells by Alamar blue assay
[PMID: 34146914]
L6 IC50
6.4 μM
Compound: FMD, DB75, Furamidine
Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay
Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay
[PMID: 23795673]
L6 IC50
6.4 μM
Compound: FMD, Furamidine
Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
[PMID: 24268543]
L6 IC50
6.4 μM
Compound: Furamidine
Cytotoxicity against rat L6 cells by alamar blue assay
Cytotoxicity against rat L6 cells by alamar blue assay
[PMID: 21194955]
L6 IC50
6.4 μM
Compound: IIa
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
[PMID: 21421317]
L6 IC50
6.5 μM
Compound: IIa
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
[PMID: 20403703]
L6 IC50
6.7 μM
Compound: Furamidine
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
[PMID: 20031421]
L6 IC50
6.7 μM
Compound: Table 1, R1C1
Cytotoxicity against rat L6 cells assessed as reduction in cell viability incubated for 70 hrs by Alamar blue based microplate fluorescence assay
Cytotoxicity against rat L6 cells assessed as reduction in cell viability incubated for 70 hrs by Alamar blue based microplate fluorescence assay
[PMID: 36958267]
L6 IC50
6400 nM
Compound: 2a
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
[PMID: 19699098]
L6 IC50
6400 nM
Compound: 2a
Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
[PMID: 24012380]
L6 IC50
6400 μM
Compound: IIa, furamidine
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
[PMID: 17976993]
SK-OV-3 IC50
42.5 μM
Compound: 2
The compound was tested for cytotoxic potency against SKOV-3 human tumor cell lines.
The compound was tested for cytotoxic potency against SKOV-3 human tumor cell lines.
10.1016/S0960-894X(97)00229-1
体外研究
(In Vitro)

Furamidine (compound 1; 20 μM; 72 hours; leukemia cell lines) inhibits cell growth for most of the leukemia cell lines except HEL cells which have JAK2V617F mutations[1].
Furamidine (compound 1; 20 μM; 15 hours; 293T cells) treatment significantly reduces the expression level of the methylated GFP-ALY protein in 293T cells[1].
Furamidine binds duplex DNA in the DNA minor groove selectively at AT rich sites [(A/T)4]. Furamidine can also intercalate between GC base pairs of duplex DNA. Furamidine could therefore interfere with DNA processing enzymes such as TDP-1[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Meg-01, K562, HL-60, NB4, MOLM13, HEL, CMK, CMY, CMS and CHRF cells
Concentration: 20 μM
Incubation Time: 72 hours
Result: Inhibited cell growth for most of the leukemia cell lines except HEL cells which have JAK2V617F mutations.

Western Blot Analysis[1]

Cell Line: 293T cells
Concentration: 20 μM
Incubation Time: 15 hours
Result: The expression level of the methylated GFP-ALY protein is significantly reduced.
体内研究
(In Vivo)

Furamidine (1 mg/kg; intraperitoneal injection; 3 times a week and repeated every 4 weeks; for 34 weeks; female NZB/NZW mice) and Irinotecan combined treatment suppresses proteinuria and prolongs survival of lupus-prone NZB/NZW mice. The combination treatment does not change the levels of anti-dsDNA antibodies[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female NZB/NZW mice (6-week-old) with Irinotecan (1 mg/kg)[3]
Dosage: 1 mg/kg
Administration: Intraperitoneal injection; 3 times a week and repeated every 4 weeks; for 34 weeks
Result: Suppressed proteinuria and prolongs survival of lupus-prone NZB/NZW mice combined with Irinotecan.
分子量

304.35

Formula

C18H16N4O

CAS 号
中文名称

呋喃脒

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Furamidine
目录号:
HY-110137A
需求量: